Rational targeting of immunosuppressive neutrophils in cancer
2020 · Pharmacology & Therapeutics · 70 citations
https://doi.org/10.1016/j.pharmthera.2020.107556
S
Sharif Rahmy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
252
Citations
7
h-index
5
i10-index
Sharif Rahmy is an academic researcher from University of Notre Dame. The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & Diet and metabolism studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 7, co-authored 25 publications.
ORCID: 0000-0002-7825-7186Papers by this author
worksKetogenic Diet Alters the Epigenetic and Immune Landscape of Prostate Cancer to Overcome Resistance to Immune Checkpoint Blockade Therapy
2024 · Cancer Research · 49 citations
https://doi.org/10.1158/0008-5472.can-23-2742
Overcome Prostate Cancer Resistance to Immune Checkpoint Therapy with Ketogenic Diet-Induced Epigenetic Reprogramming
2023 · bioRxiv (Cold Spring Harbor Laboratory) · 6 citations
https://doi.org/10.1101/2023.08.07.552383
Data from Ketogenic Diet Alters the Epigenetic and Immune Landscape of Prostate Cancer to Overcome Resistance to Immune Checkpoint Blockade Therapy
2024 · 0 citations
https://doi.org/10.1158/0008-5472.c.7234896
CDH3 as a Novel Therapeutic Target in Basal-like Double-Negative Prostate Cancer
2025 · bioRxiv (Cold Spring Harbor Laboratory) · 0 citations
https://doi.org/10.1101/2025.11.18.689150
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat